Cargoing P-gp inhibitors via nanoparticle sensitizes tumor cells against doxorubicin (original) (raw)

Surfactant–Polymer Nanoparticles Overcome P-Glycoprotein-Mediated Drug Efflux

Ayman Khdair

Molecular Pharmaceutics, 2007

View PDFchevron_right

Doxorubicin-verapamil dual loaded PLGA nanoparticles for overcoming P-glycoprotein mediated resistance in cancer: Effect of verapamil concentration

amin akbarizadeh

Journal of Drug Delivery Science and Technology, 2019

View PDFchevron_right

Evading P-glycoprotein mediated-efflux chemoresistance using Solid Lipid Nanoparticles

Marco Cavaco

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2017

View PDFchevron_right

Overcoming cellular multidrug resistance using classical nanomedicine formulations

Karel Ulbrich

European Journal of Pharmaceutical Sciences, 2012

View PDFchevron_right

Nanoparticle-directed sub-cellular localization of doxorubicin and the sensitization breast cancer cells by circumventing GST-Mediated drug resistance

Ralf Morgenstern

Biomaterials, 2014

View PDFchevron_right

Comparing cellular uptake and cytotoxicity of targeted drug carriers in cancer cell lines with different drug resistance mechanisms

Romila Manchanda

Nanomedicine: Nanotechnology, Biology and Medicine, 2011

View PDFchevron_right

Nanopreparations to overcome multidrug resistance in cancer

Vladimir Torchilin

Advanced Drug Delivery Reviews, 2013

View PDFchevron_right

Nanocarriers enhance Doxorubicin uptake in drug-resistant ovarian cancer cells

Giga Scientists

2012

View PDFchevron_right

Sterically stabilized polymeric nanoparticles with a combinatorial approach for multi drug resistant cancer: In vitro and in vivo investigations

Anita Verma

International journal of pharmaceutics, 2014

View PDFchevron_right

Environmentally responsive dual-targeting nanoparticles: improving drug accumulation in cancer cells as a way of preventing anticancer drug efflux

cenk daglioglu

Journal of pharmaceutical sciences, 2017

View PDFchevron_right

Therapeutic Nanoparticles for Drug Delivery in Cancer

Alan Lu

View PDFchevron_right

A Mechanistic Study of Enhanced Doxorubicin Uptake and Retention in Multidrug Resistant Breast Cancer Cells Using a Polymer-Lipid Hybrid Nanoparticle System

M.Kashif ur Rehman

View PDFchevron_right

Doxorubicin and MBO-asGCS oligonucleotide loaded lipid nanoparticles overcome multidrug resistance in adriamycin resistant ovarian cancer cells (NCI/ADR-RES)

Yong-Yu Liu

International journal of pharmaceutics, 2012

View PDFchevron_right

Controlled release and reversal of multidrug resistance by co-encapsulation of paclitaxel and verapamil in solid lipid nanoparticles

Jong-Suep Baek

International Journal of Pharmaceutics, 2015

View PDFchevron_right

Targeted delivery of doxorubicin into tumor cells by nanostructured lipid carriers conjugated to anti-EGFRvIII monoclonal antibody

Mohammad Javad Rasaee

Artificial Cells, Nanomedicine, and Biotechnology, 2017

View PDFchevron_right

Curcumin-Loaded Solid Lipid Nanoparticles Bypass P-Glycoprotein Mediated Doxorubicin Resistance in Triple Negative Breast Cancer Cells

Sohair Fahmy

Pharmaceutics

View PDFchevron_right

Tumor-targeting, pH-sensitive nanoparticles for docetaxel delivery to drug-resistant cancer cells

Tuan Tran

International Journal of Nanomedicine, 2015

View PDFchevron_right

Enhanced cytotoxicity and nuclear accumulation of doxorubicin-loaded nanospheres in human breast cancer MCF7 cells expressing MRP1

Bruno GIROUX

International Journal of Oncology, 2003

View PDFchevron_right

Nanoparticle-mediated simultaneous and targeted delivery of paclitaxel and tariquidar overcomes tumor drug resistance

Yogesh patil

Journal of Controlled Release, 2009

View PDFchevron_right

Effective delivery of hydrophobic drugs to breast (MCF-7) and Liver (HepG2) cancer cells: A detailed investigation using Cytotoxicity assays, fluorescence imaging and flow cytometry

Danushika Manatunga

European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 2018

View PDFchevron_right

Liposome-Encapsulated Doxorubicin Reverses Drug Resistance by Inhibiting P-Glycoprotein in Human Cancer Cells

Joanna Kopecka

Molecular Pharmaceutics, 2011

View PDFchevron_right

Bypassing Multidrug Resistance in Cancer Cells with Biodegradable Polymer Capsules

Edouard Nice

Advanced Materials, 2010

View PDFchevron_right

Activation of polymeric nanoparticle intracellular targeting overcomes chemodrug resistance in human primary patient breast cancer cells

Shaker Mousa

International Journal of Nanomedicine, 2018

View PDFchevron_right